Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Overview
Calcium binding protein P22 is a phosphoprotein that binds to sodium hydroxide exchanger (NHEs) and Ca2+. It can act as a transporter, regulator or activator to control the concentration of Ca2+ in the cytoplasm participate in various cell functions, decode Ca2+ signals, and regulate the concentration of Ca2+ in the cell.
Figure 1. Some P22 with their Locatins & Functions (http://www. apsubiology. org).
P22 and Calcium Ions
Calcium ions act as a second messenger to control a wide range of physiological effects. Disorders of intracellular calcium levels can lead to irreversible damage and even disease. Therefore, calcium homeostasis, is very important and requires very strict regulation. In cells, the role of Ca2+ is largely dependent on large amounts of P22, which has the ability to bind to this ion in specific regions. For example, the family of vertebrate ef-hand Ca2+ binding protein S100 (soluble in saturated ammonium sulfate) affects a variety of biological processes, including cell cycle progression, cell growth, cell viability, transcription and cell differentiation.
In addition, P22 controls the concentration of Ca2+ in the cytoplasm by acting as a Ca2+ transporter on the cell membrane or a Ca2+ modulation sensor participating in multiple cell functions. For example, calsyntenin is expressed on ER/golgi bodies and plasma membranes of almost all neurons regulating post-synaptic signaling and APP lysis. In presynaptic vesicles, synaptic binding protein is a highly conserved P22 that promotes the release of neurotransmitters by triggering extracellular secretions.
Structure
The P22 contains a highly conserved helix-ring-helix structure or EF chiral sequence. In general, EF chiral motifs come in pairs (EF chiral motifs) and facilitate the synergistic binding of two Ca2+ ions in each domain. However, P22s containing single or odd number of EF chiral motifs have also been found in bacteria and eukaryotes, and are thought to play a role through the dimerization mechanism.
Some of these Ca2+ binding proteins, such as CaM, the most common Ca2+ binding proteins, exist in the cytoplasm, organelles, or cell membranes of eukaryotic cells as Ca2+ receptors. Other proteins appear to act as storage devices for Ca2+ (such as calcium-flavine, calcium web). Structurally, calmodulin is an acidic protein composed of two spherical structural domains (each region has a pair of EF hands) connected by a flexible spiral region.
Role in Disease
Of the more than 200 ef-hand calcium-binding protein family members in the human body, the most studied are calretinin (CR), calbindin d-28k (CB) and parvalbumin (PV). CR is mainly expressed in granulocytes and their parallel fibers, while PV and CB are distributed in axons, somatic cells, dendrites and spinal cord of purkinje cells. Studies have shown that antibodies to CR, CB, and PV are appropriate tools for demonstrating transient features and developmental changes in human fetal brain tissue and for detecting specific changes in pathological specimens. In late pregnancy, CB and CR were expressed in a variety of nerve cells in the subplate. The subplate is a very wide area under the cortical plate, which is a "waiting room" where different cortical affections reside before entering the cortical plate. At the 7th and 8th months, the cortex mesenchymal between CB- and PV-ir was observed in the deeper part of the cortex plate. Fetal hydrocephalus results in severe changes of CB-ir and PV-ir neurons in the lower and cortical plates: contraction of ir neurons, loss of process markers, and, in most cases, total loss of immune markers. These changes, which cannot be detected in nissl stained slices, indicate significant impairment in neural function.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.